LABTRACE.ORG BETA LIVE
212 source polls this hour 82 029 articles collected last article 2m ago 1589 events on 2+ sources 0 embeddings/h feed queue 0 lag 314.8s
← health
LT-034702 / first seen 2026-10-24 19:07 / last activity 2d ago

Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer

measurement

heat
36 / 100 (raw 0.9)
velocity
0.0 independent sources per hour
solidity
98 / 100
sources
1 total, 1 independent
domain span
1 domain covered it

primary source

title
Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer
venue
New England Journal of Medicine
status
peer-reviewed
doi
10.1056/nejmoa2608323
published
2026-10-24

media coverage / 1 outlets